BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 16 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $587,000 | -21.8% | 1,679,303 | +7.8% | 0.00% | -100.0% |
Q3 2019 | $751,000 | -12.7% | 1,557,803 | +8.6% | 0.00% | 0.0% |
Q2 2019 | $860,000 | 0.0% | 1,434,538 | +8.9% | 0.00% | 0.0% |
Q1 2019 | $860,000 | -14.5% | 1,317,676 | +5.0% | 0.00% | 0.0% |
Q4 2018 | $1,006,000 | -23.2% | 1,255,476 | +3.5% | 0.00% | 0.0% |
Q3 2018 | $1,310,000 | -73.6% | 1,213,276 | -44.7% | 0.00% | -66.7% |
Q2 2018 | $4,953,000 | +130.6% | 2,192,100 | +112.2% | 0.00% | +50.0% |
Q1 2018 | $2,148,000 | -10.2% | 1,032,900 | +11.4% | 0.00% | -33.3% |
Q4 2017 | $2,392,000 | +127.6% | 927,200 | +25.3% | 0.00% | +200.0% |
Q3 2017 | $1,051,000 | +26.8% | 740,000 | +19.7% | 0.00% | 0.0% |
Q2 2017 | $829,000 | +16.6% | 618,300 | +29.5% | 0.00% | 0.0% |
Q1 2017 | $711,000 | +473.4% | 477,400 | +99.7% | 0.00% | – |
Q4 2016 | $124,000 | +59.0% | 239,100 | +330.8% | 0.00% | – |
Q3 2016 | $78,000 | +110.8% | 55,500 | +168.1% | 0.00% | – |
Q2 2016 | $37,000 | – | 20,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Puissance Capital Management LP | 8,298,755 | $6,651,000 | 7.59% |
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $16,953,000 | 1.88% |
VHCP Management II, LLC | 4,149,378 | $3,325,000 | 1.43% |
VHCP Management III, LLC | 2,274,370 | $1,823,000 | 1.32% |
ARCH Venture Management, LLC | 965,660 | $774,000 | 0.77% |
A.R.T. Advisors, LLC | 30,484 | $24,000 | 0.00% |
Virtu Financial LLC | 36,708 | $29,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $147,000 | 0.00% |
GABLES CAPITAL MANAGEMENT INC. | 1,400 | $1,000 | 0.00% |
Renaissance Technologies | 1,255,476 | $1,006,000 | 0.00% |